IRIS
FORLINO, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.725
AS - Asia 3.192
EU - Europa 2.809
SA - Sud America 498
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 11.270
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.621
CN - Cina 1.672
IE - Irlanda 722
SG - Singapore 677
BR - Brasile 413
RU - Federazione Russa 399
HK - Hong Kong 394
FI - Finlandia 341
DE - Germania 315
IT - Italia 263
UA - Ucraina 245
VN - Vietnam 224
GB - Regno Unito 142
SE - Svezia 135
FR - Francia 54
CA - Canada 52
IN - India 50
BE - Belgio 43
MX - Messico 35
AR - Argentina 32
JP - Giappone 31
PL - Polonia 27
AT - Austria 26
CZ - Repubblica Ceca 23
BD - Bangladesh 22
NL - Olanda 19
EC - Ecuador 15
ID - Indonesia 15
ES - Italia 13
TR - Turchia 13
ZA - Sudafrica 13
IQ - Iraq 11
LT - Lituania 11
CO - Colombia 9
IR - Iran 9
PY - Paraguay 8
MA - Marocco 7
SA - Arabia Saudita 7
KG - Kirghizistan 6
VE - Venezuela 6
AZ - Azerbaigian 5
CL - Cile 5
KR - Corea 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
JM - Giamaica 4
NP - Nepal 4
PK - Pakistan 4
RO - Romania 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
UZ - Uzbekistan 4
AL - Albania 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
GR - Grecia 3
IL - Israele 3
KE - Kenya 3
LV - Lettonia 3
PE - Perù 3
UY - Uruguay 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
CR - Costa Rica 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
KH - Cambogia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
TH - Thailandia 2
TM - Turkmenistan 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BN - Brunei Darussalam 1
CG - Congo 1
CY - Cipro 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
GY - Guiana 1
HU - Ungheria 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
ML - Mali 1
MU - Mauritius 1
Totale 11.260
Salva come PNG Salva come JPEG
Città #
Dallas 863
Dublin 719
Chandler 666
Hong Kong 394
Beijing 391
Ashburn 360
Singapore 329
Jacksonville 313
Nanjing 302
Ann Arbor 195
Boardman 182
Los Angeles 158
Helsinki 137
Nanchang 120
Princeton 115
Munich 114
Lawrence 112
Wilmington 102
Shenyang 99
Medford 97
Changsha 95
Pavia 87
Hebei 83
Ho Chi Minh City 82
Shanghai 78
Moscow 70
Jiaxing 68
New York 67
Hangzhou 61
Milan 61
Redondo Beach 56
Buffalo 54
Tianjin 54
Woodbridge 50
Turku 47
Brussels 43
Hanoi 43
São Paulo 40
Houston 35
Tokyo 27
The Dalles 21
Warsaw 21
Dearborn 20
Nuremberg 19
Washington 19
Fairfield 18
Montreal 18
Seattle 18
Stockholm 18
Chicago 17
Norwalk 17
San Francisco 17
Santa Clara 17
Atlanta 16
Brooklyn 16
Toronto 16
Falkenstein 14
Frankfurt am Main 14
Orem 14
Verona 14
Belo Horizonte 13
London 13
Rio de Janeiro 13
Vienna 13
Brno 12
Chennai 12
Council Bluffs 12
Jinan 12
Boston 11
Poplar 11
Columbus 10
Denver 10
Des Moines 10
Guangzhou 10
Haiphong 10
Brasília 9
Johannesburg 9
Olomouc 9
Zhengzhou 9
Ankara 8
Auburn Hills 8
Manchester 8
Mexico City 8
Ningbo 8
Biên Hòa 7
Buenos Aires 7
Hải Dương 7
Phoenix 7
Vigevano 7
Amsterdam 6
Baghdad 6
Bishkek 6
Can Tho 6
Curitiba 6
Da Nang 6
Florence 6
Kunming 6
Mumbai 6
Ninh Bình 6
Querétaro 6
Totale 7.662
Salva come PNG Salva come JPEG
Nome #
Osteogenesis Imperfecta: A Look into the Cerebellum of the Brtl Murine Model 271
A Rare Cause of Lower Extremity Ulcers: Prolidase Deficiency 165
Combined antiresorptive and new anabolic drug approach in osteogenesis imperfecta zebrafish models 163
Kinetic and structural evidences on human prolidase pathological mutants suggest strategies for enzyme functional rescue 156
A quantitative and qualitative method for direct 2-DE analysis of murine cartilage 152
Allele-specific Col1a1 silencing reduces mutant collagen in fibroblasts from Brtl mouse, a model for classical osteogenesis imperfecta. 139
Cartilage histogenesis in a murine model of chondrodysplasia 139
Molecular characterisation of six patients with prolidase deficiency: identification of the first small duplication in the prolidase gene and of a mutation generating symptomatic and asymptomatic outcomes within the same family. 138
Improved prolidase activity assay allowed enzyme kinetic characterization and faster prolidase deficiency diagnosis 136
A Mn(II)-Mn(II) center in human prolidase 133
In vivo contribution of amino acid sulfur to cartilage proteoglycan sulfation. 127
Differential expression of both extracellular and intracellular proteins is involved in the lethal or nonlethal phenotypic variation of BrtlIV, a murine model for osteogenesis imperfecta 122
Partial rescue of biochemical parameters after hematopoietic stem cell transplantation in a patient with prolidase deficiency due to two novel PEPD mutations 121
Deficient expression of the small proteoglycan decorin in a case of severe/lethal osteogenesis imperfecta. 121
Matrix disruptions, growth, and degradation of cartilage with impaired sulfation. 120
Altered signaling in the G1 phase deregulates chondrocyte growth in a mouse model with proteoglycan undersulfation. 120
Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome 119
Insights from a transgenic mouse model on the role of SLC26A2 in health and disease. 117
4-PBA ameliorates cellular homeostasis in fibroblasts from osteogenesis imperfecta patients by enhancing autophagy and stimulating protein secretion 117
Alpha 1-antitrypsin activity in subarachnoid hemorrhage. 114
Differential response to intracellular stress in the skin from osteogenesis imperfecta Brtl mice with lethal and non lethal phenotype: a proteomic approach 114
Human recombinant prolidase from eukaryotic and prokaryotic sources. Expression, purification, characterization and long-term stability studies. 113
Mutation analysis of five new patients affected by prolidase deficiency: the lack of enzyme activity causes necrosis-like cell death in cultured fibroblasts 113
Calcium activated nucleotidase 1 (CANT1) is critical for glycosaminoglycan biosynthesis in cartilage and endochondral ossification 113
Alteration of proteoglycan sulfation affects bone growth and remodeling. 112
Deposition of mutant type I collagen in the extracellular matrix of cultured dermal fibroblasts in osteogenesis imperfecta. 110
Effect of enamel matrix derivative on human periodontal fibroblasts: proliferation, morphology and root surface colonization. An in vitro study 110
Prolidase enzyme is required for extracellular matrix integrity and impacts on postnatal cerebellar cortex development 110
A base substitution at IVS-19 3'-end splice junction causes exon 20 skipping in pro alpha 2(I) collagen mRNA and produces mild osteogenesis imperfecta. 109
Characterization of a new PEPD allele causing prolidase deficiency in two unrelated patients: natural-occurrent mutations as a tool to investigate structure-function relationship. 108
Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy 108
Severely impaired bone material quality in chihuahua zebrafish resembles classical dominant human Osteogenesis Imperfecta 107
Cellular stress due to impairment of collagen prolyl hydroxylation complex is rescued by the chaperone 4-phenylbutyrate 106
Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations 105
Glycosaminoglycans show a specific periodic interaction with type I collagen fibrils. 105
A 931 + 2T-->C transition in one COL1A2 allele causes exon 16 skipping in PRO alpha 2(I) mRNA and produces moderately severe OI. 104
Loss-of-Function FANCL Mutations Associate with Severe Fanconi Anemia Overlapping the VACTERL Association 104
Lack of prolidase causes a bone phenotype both in human and in mouse 103
Optimization of a capillary electrophoretic method to detect and quantify the Gly-Pro dipeptide in complex matrices from long term cultured prolidase deficiency fibroblasts 102
TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy. 102
Multiple effects of the Na(+)/H (+) antiporter inhibitor HMA on cancer cells. 102
Early Fracture Healing is Delayed in the Col1a2 +/G610C Osteogenesis Imperfecta Murine Model 102
New perspectives on osteogenesis imperfecta. 101
Altered cytoskeletal organization characterized lethal but not surviving Brtl+/- mice: insight on phenotypic variability in osteogenesis imperfecta 100
N-benzyloxycarbonyl-L-proline: an in vitro inhibitor of prolidase. 99
The chaperone activity of 4PBA ameliorates the skeletal phenotype of Chihuahua, a zebrafish model for dominant osteogenesis imperfecta 99
N-acetylcysteine treatment ameliorates the skeletal phenotype of a mouse model of diastrophic dysplasia 98
Zebrafish Collagen Type I: Molecular and Biochemical Characterization of the Major Structural Protein in Bone and Skin 98
Loss-of-function FANCL mutations associate with severe fanconi anemia overlapping the VACTERL association 96
An alpha 2(I) glycine to aspartate substitution is responsible for the presence of a kink in type I collagen in a lethal case of osteogenesis imperfecta. 96
Extracellular matrix deposition in cultured dermal fibroblasts from four probands affected by osteogenesis imperfecta. 95
Activity of alpha 1-antitrypsin and cigarette smoking in subarachnoid haemorrhage from ruptured aneurysm. 95
In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knock-in murine model for classical, dominant osteogenesis imperfecta 95
Crtap and p3h1 knock out zebrafish support defective collagen chaperoning as the cause of their osteogenesis imperfecta phenotype 95
Identifying the structure of the active sites of human recombinant prolidase 94
Bone cell differentiation and mineralization in wild-type and osteogenesis imperfecta zebrafish are compromised by per- and poly-fluoroalkyl substances (PFAS) 93
A novel mutation in the sulphate transporter gene SLC26A2 (DTDST) specific to the Finnish population causes de la Chapelle dysplasia. 93
Decorin transfection induces proteomic and phenotypic modulation in breast cancer cells 8701-BC. 93
A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype 92
Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes 92
Cytoskeleton and nuclear lamina affection in recessive osteogenesis imperfecta: A functional proteomics perspective 90
Further delineation of CANT1 phenotypic spectrum and demonstration of its role in proteoglycan synthesis. 86
Defective proteoglycan sulfation of the growth plate zones causes reduced chondrocyte proliferation via an altered Indian hedgehog signalling 86
Alternative splicing in COL1A1 mRNA leads to a partial null allele and two in-frame forms with structural defects in non-lethal osteogenesis imperfecta. 85
PRKACB and Carney complex 83
Brittle IV Mouse Model for Osteogenesis imperfecta IV Demonstrates Postpubertal Adaptations to Improve Whole Bone Strength. 83
MCM5: A new actor in the link between DNA replication and Meier-Gorlin syndrome 82
XX males SRY negative: a confirmed cause of infertility 80
Absence of Dipeptidyl Peptidase 3 increases oxidative stress and causes bone loss 79
Evaluation of the TiMo12Zr6Fe2 alloy for orthopaedic implants: in vitro biocompatibility study by using primary human fibroblasts and osteoblasts 78
Steady-state and pulse-chase analyses of fibrillar collagen 78
Prolidase deficiency may be reversed by hematopietic stem cell transplantation: CE analysis of dipeptides in urine and monitoring of prolidase activity in blood. 77
A novel chemical chaperone ameliorates osteoblast homeostasis and extracellular matrix in osteogenesis imperfecta 77
HEM dysplasia and ichthyosis are likely laminopathies and not due to 3beta-hydroxysterol Delta14-reductase deficiency. 76
Osteogenesis imperfecta and type I collagen mutations. A lethal variant caused by a Gly910->Ala substitution in the a1(I) chain. 76
Cleavage of collagen RNA transcripts by hammerhead ribozymes in vitro is mutation-specific and shows competitive binding effects. 75
Characterization of stress response in human retinal epithelial cells. 75
Consortium of Osteogenesis Imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. 75
Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors. 74
Severe (type III) osteogenesis imperfecta due to glycine substitutions in the central domain of the collagen triple helix. 74
Molecular stability of chemically modified collagen triple helices 74
Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine 74
Use of the Cre/Lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution. Variability in phenotype in BrtlIV mice. 73
Paternal mosaicism for a COL1A1 dominant mutation (alpha 1 Ser-415) causes recurrent osteogenesis imperfecta. 73
Prolidase Deficiency: case reports of two Argentinian brothers. 72
Osteogenesis imperfecta 72
Deletions of the PRKAR1A locus at 17q24.2-q24.3 in Carney complex: genotype-phenotype correlations and implications for genetic testing. 71
Novel RPL13 Variants and Variable Clinical Expressivity in a Human Ribosomopathy With Spondyloepimetaphyseal Dysplasia 71
Systemic lupus erythematosus-like disease in a 6-year-old boy with prolidase deficiency 70
Flavivirus antagonism of type i interferon signaling reveals prolidase as a regulator of IFNAR1 surface expression 70
Phenotypic comparison of an osteogenesis imperfecta type IV proband with a de novo alpha2(I) Gly922 --> Ser substitution in type I collagen and an unrelated patient with an identical mutation. 69
Knocking out TMEM38B in human foetal osteoblasts hFOB 1.19 by CRISPR/Cas9: A model for recessive OI type XIV 69
Targeting cellular stress in vitro improves osteoblast homeostasis, matrix collagen content and mineralization in two murine models of osteogenesis imperfecta 69
The administration of exogenous HSP47 as a collagen-specific therapeutic approach 68
Candidate cell and matrix interaction domains on the collagen fibril, the predominant protein of vertebrates. 68
Osteogenesis Imperfecta: prospects for molecular therapeutics. 66
Selective retention and degradation of molecules with a single mutant alpha1(I) chain in the Brtl IV mouse model of OI 66
Testing the Cre-mediated genetic switch for the generation of conditional knock-in mice 66
Phenotypic characterization of immortalized chondrocytes from a desbuquois dysplasia type 1 mouse model: A tool for studying defects in glycosaminoglycan biosynthesis 66
Osteoblasts mineralization and collagen matrix are conserved upon specific Col1a2 silencing 64
Totale 9.856
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.413
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021352 0 0 0 0 0 58 13 89 29 77 67 19
2021/2022538 9 13 10 12 10 6 14 39 29 14 80 302
2022/20231.920 185 177 12 150 199 155 7 114 831 18 46 26
2023/2024733 106 135 26 37 65 166 18 64 10 33 39 34
2024/20252.242 69 142 70 60 91 93 92 149 572 80 269 555
2025/20263.319 410 624 907 605 606 167 0 0 0 0 0 0
Totale 11.532